Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Strydom

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Neurobiology of Disease|February 6, 2024
Investigating brain alterations in the Dp1Tyb mouse model of Down syndromeMaria Elisa Serrano, Eugene Kim, Bernard Siow, et al.
Journal of Neurodevelopmental Disorders|March 24, 2022
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working groupNicole T Baumer, Mara L Becker, George T Capone, et al.
Health Technology Assessment (Winchester, England)|March 30, 2018
Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCTAngela Hassiotis, Michaela Poppe, Andre Strydom, et al.
Scientific Reports|June 30, 2021
The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome populationSarah E Pape, Tamara Al Janabi, Nicholas J Ashton, et al.
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Acta Neuropathologica|May 18, 2018
Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's diseaseDavid M A Mann, Yvonne S Davidson, Andrew C Robinson, et al.
Plos One|June 3, 2026
Prevalence of multiple morbidities and cancers in individuals with Down syndrome: A matched descriptive study using linked electronic health record dataCaoimhe McKenna, Kabir Yoshinori Khanna, Meghan A Cupp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoringMelissa E Petersen, Lisi Flores-Aguilar, Elizabeth Head, et al.
Bjpsych Bulletin|September 6, 2023
A tool for safer prescribing in vulnerable adults: the continuing development of the Medichec app and websiteDelia Bishara, Sahar Riaz, Justin Sauer, et al.
International Journal of Geriatric Psychiatry|November 4, 2014
Dementia diagnostic criteria in Down syndromeRory Sheehan, Amanda Sinai, Nick Bass, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Neurobiology of Disease|February 6, 2024
Investigating brain alterations in the Dp1Tyb mouse model of Down syndromeMaria Elisa Serrano, Eugene Kim, Bernard Siow, et al.
Journal of Neurodevelopmental Disorders|March 24, 2022
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working groupNicole T Baumer, Mara L Becker, George T Capone, et al.
Health Technology Assessment (Winchester, England)|March 30, 2018
Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCTAngela Hassiotis, Michaela Poppe, Andre Strydom, et al.
Scientific Reports|June 30, 2021
The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome populationSarah E Pape, Tamara Al Janabi, Nicholas J Ashton, et al.
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Acta Neuropathologica|May 18, 2018
Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's diseaseDavid M A Mann, Yvonne S Davidson, Andrew C Robinson, et al.
Plos One|June 3, 2026
Prevalence of multiple morbidities and cancers in individuals with Down syndrome: A matched descriptive study using linked electronic health record dataCaoimhe McKenna, Kabir Yoshinori Khanna, Meghan A Cupp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoringMelissa E Petersen, Lisi Flores-Aguilar, Elizabeth Head, et al.
Bjpsych Bulletin|September 6, 2023
A tool for safer prescribing in vulnerable adults: the continuing development of the Medichec app and websiteDelia Bishara, Sahar Riaz, Justin Sauer, et al.
International Journal of Geriatric Psychiatry|November 4, 2014
Dementia diagnostic criteria in Down syndromeRory Sheehan, Amanda Sinai, Nick Bass, et al.
Pageof 12